Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance

An important key to clinical management of prostate cancer patients is to determine early those who will benefit from primary treatment and are not good candidates for active surveillance (AS). We describe a 67-year-old gentleman with a long history of stable prostate-specific antigen (PSA) levels a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandler, Kiri, Patel, Mausam, Lynne, Charles, Parekh, Dipen J., Punnen, Sanoj, Jorda, Merce, Casillas, Javier, Pollack, Alan, Stoyanova, Radka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306300/
https://www.ncbi.nlm.nih.gov/pubmed/25674540
http://dx.doi.org/10.3389/fonc.2015.00004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306300/
https://www.ncbi.nlm.nih.gov/pubmed/25674540
http://dx.doi.org/10.3389/fonc.2015.00004

Ejemplares similares